Real-World Adherence and Effectiveness of Inclisiran in Lowering LDL-C: Results from 1 Year of Follow-Up
Abstract Introduction Atherosclerotic cardiovascular disease (ASCVD) is a global health concern. Reducing low-density lipoprotein cholesterol (LDL-C) is critical in ASCVD prevention and treatment. Inclisiran, a novel RNA therapeutic agent, offers a promising solution by lowering LDL-C with twice-yea...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Adis, Springer Healthcare
2025-11-01
|
| Schriftenreihe: | Cardiology and Therapy |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s40119-025-00438-0 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|